Daily Herald

FDA investigates Zyprexa Relprevv patient deaths

Federal regulators are investigating the deaths of two patients who received injections of a longer-lasting version of Eli Lilly’s antipsychotic Zyprexa. The Food and Drug Administration said Tuesday ...
Monthly Prescribing Reference

FDA Finishes Review of Patient Deaths Post-Zyprexa Relprevv Injection

The Food and Drug Administration (FDA) stated that study results were inconclusive regarding the investigation of two deaths following the injection of Zyprexa Relprevv (olanzapine pamoate ...
FiercePharma

FDA probes long-acting Zyprexa safety after 2 patients die

Two patients have died unexpectedly after their Zyprexa Relprevv injections, and the FDA is now investigating. The agency says the patients died three to four days after receiving "an appropriate dose ...
Monthly Prescribing Reference

Alert: Zyprexa Relprevv Linked to Two Deaths

Alert: Zyprexa Relprevv Linked to Two Deaths Two patients died 3-4 days after receiving an intramuscular injection of Zyprexa Relprevv (olanzapine pamoate extended-release). The patients were found to ...
FierceBiotech

FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults

Long-acting injection provides therapeutic olanzapine exposure for up to four weeks INDIANAPOLIS, Dec 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- The U.S. Food and Drug Administration ...
Chicago Tribune

FDA probes deaths of two patients on Lilly schizophrenia drug

(Reuters) – The Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co’s long-acting treatment for schizophrenia, Zyprexa Relprevv.
The Business Journals

FDA investigates deaths of patients who took Zyprexa Relprevv

The U.S. Food and Drug Administration (FDA) is investigating two unexplained deaths in patients who received the antipsychotic drug Zyprexa Relprevv. Editor's Note: An earlier version of this story ...